News & Updates
Drug makers are linking with eight British universities in a 16 million-pound ($27 million) public-private partnership to speed research into dementia by studying data from 2 million people. The new UK Dementias Research Platform will investigate the causes of dementia by tracking volunteers, aged 50 and over, who are taking part in existing population studies.
The California Department of Insurance tapped the University of California and the San Francisco-based Consumers Union to create a health care price transparency and quality database that will launch within a year. The database will rely on existing data streams, such as claims data from the Centers for Medicare & Medicaid Services and from private payers.
Flurry Analytics reported that health and fitness apps are growing at a faster rate than the overall app market so far in 2014. Flurry looked at data from more than 6,800 health and fitness and found that usage (measured in sessions) is up 62% in the last six months compared to 33% growth for the entire market, an 87% faster pace.
WebMD has filed a lawsuit against Everyday Health for trademark infringement, false advertising and unfair competition. The lawsuit claims that consumers are being misled into believing they are visiting WebMD’s health and wellness resources. Everyday Health believes that the allegations do not hold merit, and is ready to defend itself.
Dress.UP Fitness Bracelets, a Canada based fitness accessory maker, launched a new line of fitness wristband covers for the Fitbit Flex. It is aimed towards motivating women to incorporate wristband fitness trackers into their wardrobe outside of the gym by transforming their tracker into a chic fashion accessory suitable for evening wear.
Ideomed, a Michigan-based developer of mobile health solutions, received a word from the FDA that its mobile health app Abriiz meets the definition of a “medical device” for which the FDA intends to exercise “Enforcement Discretion” i.e. “it is not subject to further FDA regulatory requirements at this time”. Hence, Abriiz can be connected to other FDA-regulated devices including blood glucose monitors, pulse oximeters, scales and blood pressure cuffs.
Mercer launched Mercer/Signal: US Health Care Reform, a content portal containing information and insight on the rapidly transforming health care environment. It will feature Mercer’s own research and observations, as well as draw content from other credible sources, with commentary added by Mercer’s experts.